In rodent models, sEH inhibition or genetic deletion of EPHX2 attenuates renal damage due to hypertension [32, 33], salt-sensitive hypertension [34, 35], diabetes [36], and IR injury [16]. The gene discussed is EPHX2; the disease is hypertensive disorder.